Evidence map›Paper›PMID 25526664›Full record

SynthesisBMC pediatrics2014

Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials.

Hui Jin, Yueyuan Zhao, Zhaoying Tan, Xuefeng Zhang, Yaoyun Zhao, Bei Wang, Pei Liu

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in BMC pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Viral hepatitis vaccination during pregnancy.Human vaccines & immunotherapeutics · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hui JinDepartment of Epidemiology and Health Statistics, Southeast University, Nanjing, China. jinhui_hld@163.com.
Yueyuan ZhaoDepartment of Epidemiology and Health Statistics, Southeast University, Nanjing, China. zhaoyy@163.com.
Zhaoying TanJiangsu Provincial Centre for Disease Control and Prevention, Nanjing, China. tan671111@163.com.
Xuefeng ZhangJiangsu Provincial Centre for Disease Control and Prevention, Nanjing, China. njzhangxf@126.com.
Yaoyun ZhaoDepartment of Epidemiology and Health Statistics, Southeast University, Nanjing, China. zhaoyj@163.com.
Bei WangDepartment of Epidemiology and Health Statistics, Southeast University, Nanjing, China. wangbeilxb@seu.edu.cn.
Pei LiuDepartment of Epidemiology and Health Statistics, Southeast University, Nanjing, China. liupeiseu@163.com.
Southeast University · CNJiangsu Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to determine the clinical efficacy of various immune interventions on mother-to-child transmission (MTCT) of hepatitis B virus (HBV).

methodsWe retrieved different immune strategies on how to prevent MTCT reported in the literature from Chinese and English electronic databases from the viewpoint of intrauterine and extrauterine prevention. Relative risk (RR) and 95% confidence interval (CI) methods were used.

resultsTwenty-five articles on intrauterine prevention and 16 on extrauterine prevention were included in the analysis. Intrauterine prevention could reduce infants' HBV infection rate (RR = 0.36, 95% CI: 0.28-0.45) and increase their anti-hepatitis B surface-positive rate (RR = 2.42, 95% CI: 1.46-4.01) at birth. Compared with passive immunization, passive-active immunization could reduce infants' HBV infection rate (RR = 0.66, 95% CI: 0.52-0.84) at birth, even at more than 12 months of age (RR = 0.54, 95% CI: 0.42-0.69). Subgroup analysis demonstrated similar results except for pregnant women who were hepatitis B surface antigen-positive. Funnel plots and Egger's tests showed publication bias mainly in intrauterine prevention not in extrauterine one.

conclusionsThe long-term protective effect of pregnant women injected with hepatitis B immunoglobulin during pregnancy should be further validated by large-scale randomized trials. Newborns of pregnant women who carried HBV should undergo a passive-active immunization strategy.

Indexed as

Immunization, PassiveCarrier StateFemaleHepatitis BHepatitis B virusHumansImmunoglobulinsInfectious Disease Transmission, VerticalPregnancyPregnancy Complications, InfectiousRandomized Controlled Trials as TopicViral Hepatitis Vaccineshepatitis B hyperimmune globulinImmunoglobulinsViral Hepatitis Vaccines

Identifiers

PMID25526664
PMCPMC4297423
OpenAlexW2018346982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.